DYNAVAX TECHNOLOGIES CORPORATION MANAGEMENT CONTINUITY AND SEVERANCE AGREEMENTManagement Continuity and Severance Agreement • June 5th, 2009 • Dynavax Technologies Corp • Pharmaceutical preparations • California
Contract Type FiledJune 5th, 2009 Company Industry JurisdictionThis Management Continuity and Severance Agreement (the “Agreement”) is dated as of April 22, 2009, by and between Zbigniew Janowicz, Chief Executive Officer and Managing Director, Rhein Biotech GmbH, Dynavax Technologies Corporation ("Employee"), and Dynavax Technologies Corporation, a Delaware corporation (the "Company" or “Dynavax”).
DYNAVAX TECHNOLOGIES CORPORATION MANAGEMENT CONTINUITY AND SEVERANCE AGREEMENT Amended October 3, 2008Management Continuity and Severance Agreement • March 6th, 2009 • Dynavax Technologies Corp • Pharmaceutical preparations • California
Contract Type FiledMarch 6th, 2009 Company Industry JurisdictionThis Management Continuity and Severance Agreement (the “Agreement”) is dated as of [DATE], by and between [NAME OF EXECUTIVE OFFICER], [TITLE OF EXECUTIVE OFFICER], Dynavax Technologies Corporation (“Employee”), and Dynavax Technologies Corporation, a Delaware corporation (the “Company” or “Dynavax”).
DYNAVAX TECHNOLOGIES CORPORATION MANAGEMENT CONTINUITY AND SEVERANCE AGREEMENT Amended October 3, 2008Management Continuity and Severance Agreement • March 6th, 2009 • Dynavax Technologies Corp • Pharmaceutical preparations • California
Contract Type FiledMarch 6th, 2009 Company Industry JurisdictionThis Management Continuity and Severance Agreement (the “Agreement”) is dated as of October 15, 2003, by and between Dino Dina, President and Chief Executive Officer, Dynavax Technologies Corporation (“Employee”), and Dynavax Technologies Corporation, a Delaware corporation (the “Company” or “Dynavax”).